Novo Nordisk
NVO
#79
Rank
โ‚น19.775 T
Marketcap
โ‚น4,447
Share price
-0.51%
Change (1 day)
-38.45%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.799 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.70 Billion. , an increase over its 2024 earnings that were of โ‚น1.713 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น1.869 T9.13%
2024 โ‚น1.713 T22.84%
2023 โ‚น1.394 T57.81%
2022 โ‚น883.93 B5.24%
2021 โ‚น839.95 B12.38%
2020 โ‚น747.40 B13.11%
2019 โ‚น660.78 B-3.45%
2018 โ‚น684.39 B1.88%
2017 โ‚น671.74 B4.3%
2016 โ‚น644.03 B10.32%
2015 โ‚น583.77 B7.47%
2014 โ‚น543.21 B3.4%
2013 โ‚น525.34 B19.09%
2012 โ‚น441.14 B15.58%
2011 โ‚น381.68 B16.58%
2010 โ‚น327.41 B25.66%
2009 โ‚น260.56 B10.68%
2008 โ‚น235.42 B55.82%
2007 โ‚น151.09 B7.02%
2006 โ‚น141.17 B19.05%
2005 โ‚น118.58 B10.55%
2004 โ‚น107.26 B
2002 โ‚น75.18 B-14.39%
2001 โ‚น87.81 B-52.82%
2000 โ‚น186.12 B250%
1999 โ‚น53.17 B31.21%
1998 โ‚น40.52 B34.31%
1997 โ‚น30.17 B11.46%
1996 โ‚น27.07 B9.03%
1995 โ‚น24.82 B-3.15%
1994 โ‚น25.63 B-0.67%
1993 โ‚น25.80 B45.38%
1992 โ‚น17.75 B-13.81%
1991 โ‚น20.59 B37.12%
1990 โ‚น15.02 B-0.79%
1989 โ‚น15.13 B26.2%
1988 โ‚น11.99 B24.97%
1987 โ‚น9.59 B-0.9%
1986 โ‚น9.68 B-7.78%
1985 โ‚น10.50 B24.87%
1984 โ‚น8.41 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.073 T-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.037 T 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น823.91 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น727.29 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA